Lecap Asset Management Ltd. raised its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 43.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 106,629 shares of the company's stock after purchasing an additional 32,345 shares during the quarter. Bath & Body Works accounts for 0.8% of Lecap Asset Management Ltd.'s holdings, making the stock its 20th largest holding. Lecap Asset Management Ltd.'s holdings in Bath & Body Works were worth $3,233,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Bath & Body Works by 32.6% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 52,784 shares of the company's stock valued at $2,046,000 after purchasing an additional 12,964 shares during the period. PNC Financial Services Group Inc. grew its stake in shares of Bath & Body Works by 5.5% in the fourth quarter. PNC Financial Services Group Inc. now owns 88,423 shares of the company's stock valued at $3,428,000 after buying an additional 4,625 shares in the last quarter. Kovitz Investment Group Partners LLC acquired a new stake in shares of Bath & Body Works in the fourth quarter valued at $258,000. Merit Financial Group LLC acquired a new stake in shares of Bath & Body Works in the first quarter valued at $714,000. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Bath & Body Works by 13.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,704,625 shares of the company's stock valued at $66,088,000 after buying an additional 195,813 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.
Analysts Set New Price Targets
BBWI has been the subject of a number of research reports. UBS Group lifted their price objective on Bath & Body Works from $32.00 to $36.00 and gave the company a "neutral" rating in a research note on Tuesday, May 20th. Robert W. Baird boosted their target price on Bath & Body Works from $45.00 to $47.00 and gave the stock an "outperform" rating in a research note on Friday, February 28th. Piper Sandler set a $39.00 target price on Bath & Body Works and gave the stock an "overweight" rating in a research note on Thursday, May 15th. Raymond James Financial lowered their target price on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a research note on Thursday, April 17th. Finally, Telsey Advisory Group reissued an "outperform" rating and set a $38.00 target price (down from $43.00) on shares of Bath & Body Works in a research note on Thursday, May 29th. Four investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, Bath & Body Works has an average rating of "Moderate Buy" and an average price target of $42.00.
Read Our Latest Report on Bath & Body Works
Bath & Body Works Trading Up 3.3%
BBWI stock traded up $0.96 on Friday, hitting $30.10. The company's stock had a trading volume of 5,144,822 shares, compared to its average volume of 5,142,865. The firm has a 50 day moving average of $29.51 and a two-hundred day moving average of $32.95. Bath & Body Works, Inc. has a 1 year low of $24.94 and a 1 year high of $41.87. The stock has a market cap of $6.37 billion, a price-to-earnings ratio of 8.03, a price-to-earnings-growth ratio of 1.04 and a beta of 1.72.
Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Thursday, May 29th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.47 by $0.02. The firm had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.42 billion. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. Bath & Body Works's revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.38 EPS. As a group, equities analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 6th were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, June 6th. This represents a $0.80 dividend on an annualized basis and a yield of 2.66%. Bath & Body Works's payout ratio is currently 21.33%.
Bath & Body Works Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Recommended Stories

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.